Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome.
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022148. doi: 10.5826/dpc.1204a148. eCollection 2022 Nov.
Dermatol Pract Concept. 2022.
PMID: 36534565
Free PMC article.